Search clinical trials for: Monosialoganglioside Ganglioside

Total 18 results

General Hospital of Shenyang Military Region
The Third Xiangya Hospital of Central South University

Completed

An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke

Stroke, Ischemic

China
Thomas Jefferson University
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

GM1 Ganglioside Effects on Parkinson's Disease

Parkinson Disease

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Recruiting

Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

Anatomic Stage IV Breast Cancer AJCC v8 | Chemotherapy-Induced Peripheral Neuropathy | Metastatic Breast Carcinoma

United States
Sun Yat-sen University

Completed

Effect of GM1 in Prevention of Taxanes Induced Neurotoxicity in Operable Breast Cancer

Breast Cancer

China
Peking University Cancer Hospital & Institute
Peking University First Hospital; Peking Union Medical College Hospital; Cancer... and other collaborators

Unknown

Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients

Neurotoxicity

China
University of Alberta

Withdrawn

Milk-derived Gangliosides for Inflammatory Bowel Disease

Inflammatory Bowel Disease

Canada
DDC Clinic - Center for Special Needs Children

Unknown

Oral Supplementation of Gangliosides to Treat a Rare Metabolic Disorder

GM3 Synthase Deficiency
Sun Yat-sen University

Recruiting

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Breast Cancer | Chemotherapy-Related Cognitive Impairment

China
Sun Yat-sen University
Southern Medical University, China

Unknown

Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients

Non-small Cell Lung Cancer

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer

To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients
MabVax Therapeutics, Inc.

Completed

Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease Free

Sarcoma

United States
Zhejiang Cancer Hospital

Unknown

Monosialoganglioside Ganglioside in Cerebral Radiation Necrosis

Cerebral Radiation Necrosis

China
Henan Cancer Hospital

Withdrawn

GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel

Early Breast Cancer

China
Henan Cancer Hospital

Completed

A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity

Early Breast Cancer

China
Sun Yat-sen University

Recruiting

GM1 Prophylaxis for WBRT Related Cognitive Dysfunction (GLORY)

Breast Cancer | Cognitive Impairment | Brain Metastases | Radiotherapy Side Effect | Gangliosidosis, GM1

China
R. Laura Vicente Vicente
Instituto de Investigación Biomédica de Salamanca; University of Salamanca; Hospital...

Recruiting

Immune Checkpoint Inhibitors Nephrotoxicity

Kidney Injury | Antineoplastics Toxicity

Spain
Children's Hospital Medical Center, Cincinnati
Uganda Heart Institute

Recruiting

GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial

Rheumatic Heart Disease

Uganda
Menarini Group

Completed

Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee (ALBATROSS-3)

Knee Osteoarthritis

United States, Italy, Germany, Czech Republic

Search clinical trials for: Monosialoganglioside Ganglioside

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations